ATARA BIOTHERAPEUTICS INC
ATRA·046513206·US·Common Stock·Healthcare - Biotechnology-Activist
ATRA (ATARA BIOTHERAPEUTICS INC) is held by 24 institutional investors as of Q1 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($3.3M), MACKENZIE FINANCIAL CORP ($1.5M), VANGUARD CAPITAL MANAGEMENT LLC ($1M). Net institutional sentiment: Mixed.
24
Holders
Avg rating(6 Elite)
$8.5M
Total Value
54% (34)
Fund Consensus
14 buying - 12 selling
Who's Trading
ActivistRERedmile Group, LLC9.9%May 14, 2026
ActivistADAdage Capital Management, L.P.8.6%May 13, 2026
ActivistPIPanacea Innovation Limited16.1%May 11, 2026
InsiderPLPanacea Innovation LtdSell $3.2MMay 7, 2026
ActivistECEcoR1 Capital, LLC17.4%May 7, 2026
InsiderNANguyen AnhCoSell $1KMar 2, 2026
InsiderNANguyen AnhCoSell $294.64Mar 2, 2026
InsiderNANguyen AnhCoSell $7KMar 2, 2026
InsiderNANguyen AnhCoSell $7KMar 2, 2026
13F: Insider & Congress:
Showing 1-20 of 34
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer